Open Access Green as soon as Postprint is submitted to ZB.
Spatially resolved quantification of Gadolinium(III)-based magnetic resonance agents in tissue by MALDI imaging mass spectrometry after in vivo MRI.
Angew. Chem.-Int. Edit. 54, 4279-4283 (2015)
Gadolinium(III)-based contrast agents improve the sensitivity and specificity of magnetic resonance imaging (MRI), especially when targeted contrast agents are applied. Because of nonlinear correlation between the contrast agent concentration in tissue and the MRI signal obtained in vivo, quantification of certain biological or pathophysiological processes by MRI remains a challenge. Up to now, no technology has been able to provide a spatially resolved quantification of MRI agents directly within the tissue, which would allow a more precise verification of in vivo imaging results. MALDI imaging mass spectrometry for spatially resolved in situ quantification of gadolinium(III) agents, in correlation to in vivo MRI, were evaluated. Enhanced kinetics of Gadofluorine M were determined dynamically over time in a mouse model of myocardial infarction. MALDI imaging was able to corroborate the in vivo imaging MRI signals and enabled in situ quantification of the gadolinium probe with high spatial resolution.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
11.261
2.298
19
20
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Biochemistry ; Gadolinium ; Imaging Agents ; Kinetics ; Mass Spectrometry; Contrast Agents; Atherosclerotic Plaque; High-resolution; Ionization; Complexes
Language
english
Publication Year
2015
HGF-reported in Year
2015
ISSN (print) / ISBN
1433-7851
e-ISSN
1521-3773
Quellenangaben
Volume: 54,
Issue: 14,
Pages: 4279-4283
Publisher
Wiley
Publishing Place
Weinheim
Reviewing status
Peer reviewed
POF-Topic(s)
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30205 - Bioengineering and Digital Health
30205 - Bioengineering and Digital Health
Research field(s)
Enabling and Novel Technologies
PSP Element(s)
G-500300-001
G-500390-001
G-500390-001
PubMed ID
25689595
WOS ID
WOS:000351679600023
Scopus ID
84925596698
Scopus ID
84923260594
Erfassungsdatum
2015-02-19